California Healthcare Institute (CHI) Responds to FDA Initiatives to Transform the Medical Device 510(k) Review Process

(BUSINESS WIRE)--CHI-California Healthcare Institute today released a statement in response to new U.S. Food and Drug Administration (FDA) recommendations that could transform the 510(k) regulatory review process for new medical devices, greatly affecting innovation and public health in California.